Quick Answer
BeOne Medicines Ltd. reported Shares Outstanding of 1.44 billion shares for fiscal year 2025.
BeOne Medicines Ltd. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 1.44B | +3.9% |
| 2024 | 1.39B | +2.0% |
| 2023 | 1.36B | +0.2% |
| 2022 | 1.36B | +1.6% |
| 2021 | 1.33B | +12.1% |
| 2020 | 1.19B | +48.6% |
| 2019 | 801.34M | +3.2% |
| 2018 | 776.26M | +31.1% |
| 2017 | 592.07M | +14.8% |
| 2016 | 515.83M | +344.0% |
| 2015 | 116.17M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 1.44B | +3.8% | +0.7% |
| June 30, 2025 | 1.43B | +3.6% | +1.8% |
| March 31, 2025 | 1.40B | +3.2% | +1.1% |
| December 31, 2024 | 1.39B | +2.0% | +0.1% |
| September 30, 2024 | 1.39B | +2.4% | +0.5% |
| June 30, 2024 | 1.38B | +0.2% | +1.4% |
| March 31, 2024 | 1.36B | -0.2% | +0.0% |
| December 31, 2023 | 1.36B | +0.2% | +0.5% |
- BeOne Medicines Ltd. showed an increase of +3.9% in Shares Outstanding compared to the prior fiscal year.
- Over the 2015–2025 period, BeOne Medicines Ltd.’s shares outstanding has grown by 1140.4% (from 116.17 million shares to 1.44 billion shares).
- The most recent figure is from BeOne Medicines Ltd.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: